Winrho Sdf


Indications and Reactions:

Role Indications Reactions
Primary
Idiopathic Thrombocytopenic Purpura 71.6%
Thrombocytopenia 6.5%
Autoimmune Thrombocytopenia 5.4%
Rhesus Haemolytic Disease Of Newborn 3.7%
Thrombocytopenic Purpura 3.1%
Foetal-maternal Haemorrhage 2.0%
Immune Thrombocytopenic Purpura 2.0%
Prophylaxis Against Rh Isoimmunisation 1.4%
Blood Product Transfusion 0.9%
Haemorrhage 0.9%
Isoimmune Haemolytic Disease 0.6%
Platelet Count Decreased 0.6%
Abortion Threatened 0.3%
Anaemia Haemolytic Autoimmune 0.3%
Dengue Fever 0.3%
Prophylaxis 0.3%
Rhesus Incompatibility 0.3%
Vomiting 13.2%
Pyrexia 11.9%
Haemolysis 8.6%
Intravascular Haemolysis 7.9%
Tremor 7.9%
Transfusion Reaction 7.3%
Renal Failure 6.0%
Sepsis 4.6%
Thrombocytopenia 4.0%
White Blood Cell Count Increased 4.0%
Pain In Extremity 3.3%
Urine Colour Abnormal 3.3%
Haemoglobin Decreased 2.6%
Overdose 2.6%
Weight Increased 2.6%
Pain 2.0%
Renal Failure Acute 2.0%
Somnolence 2.0%
Tachypnoea 2.0%
Therapy Non-responder 2.0%
Secondary
Idiopathic Thrombocytopenic Purpura 59.2%
Thrombocytopenia 22.3%
Rhesus Haemolytic Disease Of Newborn 9.8%
Blood Product Transfusion 1.6%
Haemorrhage 1.6%
Immune Thrombocytopenic Purpura 1.6%
Autoimmune Thrombocytopenia 1.4%
Thrombocytopenic Purpura 1.1%
Foetal-maternal Haemorrhage 0.8%
Prophylaxis 0.5%
Spinal Cord Compression 8.2%
Transfusion Reaction 8.2%
Anti Factor Xi Antibody Positive 7.1%
Neutropenia 7.1%
Vomiting 7.1%
Weight Increased 7.1%
Haemolysis 5.9%
Hepatitis C 5.9%
Pyrexia 5.9%
Tremor 5.9%
Oxygen Saturation Decreased 4.7%
Peripheral Coldness 4.7%
Urinary Bladder Haemorrhage 4.7%
Tachypnoea 3.5%
Anaphylactoid Reaction 2.4%
Drug Exposure During Pregnancy 2.4%
Hepatitis C Positive 2.4%
Intravascular Haemolysis 2.4%
Placenta Praevia 2.4%
Renal Failure Acute 2.4%

Drug Data